BRIEF published on 04/01/2026 at 18:05, 6 days 8 hours ago Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF published on 03/11/2026 at 18:35, 27 days 7 hours ago Inoviem Scientific Advances Drug Development with Patient-Centric Approach Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
PRESS RELEASE published on 03/11/2026 at 18:30, 27 days 7 hours ago ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF published on 03/11/2026 at 18:20, 27 days 7 hours ago Inoviem Scientific: Advances in Pharmaceutical Development Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
BRIEF published on 02/18/2026 at 18:35, 1 month 17 days ago Hadrien Lanvin Appointed Deputy CEO of Aton Group Biotechnology Strategic Growth Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 02/18/2026 at 18:35, 1 month 17 days ago Hadrien Lanvin appointed Deputy Managing Director of the Aton Group Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group
PRESS RELEASE published on 02/18/2026 at 18:30, 1 month 17 days ago ATON APPOINTS HADRIEN LANVIN AS DEPUTY CEO Aton Group appoints Hadrien Lanvin as Deputy CEO to drive value and visibility, strengthening leadership and strategic positioning. Focus on maximizing asset portfolio valuation and accelerating development Valuation Leadership Deputy CEO Hadrien Lanvin Aton Group
BRIEF published on 10/31/2025 at 18:05, 5 months 7 days ago 2025 Half-Year Results: Aton Confirms its Recovery Financial Recovery 2025 Results PIMS Technology Inoviem Scientific B Cell Design
BRIEF published on 10/08/2025 at 18:05, 5 months 30 days ago Strategic partnership between Inoviem Scientific and abc biopply in preclinical oncology Strategic Partnership 3D Models Therapeutic Innovation Preclinical Oncology Translational Pharmacology
BRIEF published on 09/29/2025 at 08:05, 6 months 8 days ago ATON Presents its New Strategy at the European MidCap Event 2025 Investors Governance Financial Strategy Aton European MidCap
Published on 04/08/2026 at 01:35, 34 minutes ago Polaris Renewable Energy Announces Q1 2026 Investor Call Details
Published on 04/08/2026 at 00:40, 1 hour 29 minutes ago Relevant Gold Announces Initial Closing of Strategic Financing
Published on 04/08/2026 at 00:10, 1 hour 59 minutes ago Trans Canada Gold Completes the Acquisition of the Harrison Lake District Scale Gold Property and First Tranche of the Non-Brokered Private Placement
Published on 04/08/2026 at 00:00, 2 hours 9 minutes ago Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
Published on 04/07/2026 at 22:30, 3 hours 39 minutes ago Kalo Gold Enters into Investor Relations and Marketing Services Agreements
Published on 04/08/2026 at 01:30, 39 minutes ago DFC Funding Positions PELA to Deliver Critical Antimony Supply to U.S. and Allied Markets
Published on 04/07/2026 at 16:32, 9 hours 37 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 9 hours 39 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 11 hours 9 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 17:57, 8 hours 12 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 8 hours 24 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 8 hours 31 minutes ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
Published on 04/07/2026 at 17:35, 8 hours 34 minutes ago Disclosure of the number of shares and the total number of voting rights as of March 31, 2026
